Skip to main content

Table 1 Selected auxological and hormonal data of the patients with respect to the initial diagnosis

From: Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications

 

Diagnosis

p

 

GHD

NSD

inactGH

 

n

36

23

16

 

Before rhGH administration

age [years]

12.0 ± 2.4

12.0 ± 2.9

12.9 ± 1.4

0.56

height SDS

-2.59 ± 0.53

-2.91 ± 0.68

-2.68 ± 0.49

0.57

TSH [mU/l]

2.42 ± 0.91

2.18 ± 1.02

2,63 ± 0.94

0.69

FT4 [ng/dl]

1.31 ± 0.13

1.28 ± 0.17

1.29 ± 0.15

0.45

IGF-I SDS

-1.77 ± 0.92

-2.18 ± 1.23

-2.36 ± 1.06

0.58

IGF-I/IGFBP-3

0.21 ± 0.08

0.16 ± 0.05

0.16 ± 0.05

0.31

After 3-6 months of rhGH therapy

TSH [mU/l]

2.80 ± 1.28

2.60 ± 1.20

2.56 ± 1.60

0.77

FT4 [ng/dl]

1.13 ± 0.17

1.13 ± 0.19

1.13 ± 0.13

0.73

IGF-I SDS

0.33 ± 0.99

0.40 ± 0.89

0.33 ± 0.74

0.38

IGF-I/IGFBP-3

0.38 ± 0.13

0.37 ± 0.11

0.38 ± 0.11

0.86

After 1 year of rhGH therapy

TSH [mU/l]

2.51 ± 1.23

2.15 ± 0.74

1.56 ± 0.45

0.005

FT4 [ng/dl]

1.29 ± 0.18

1.27 ± 0.18

1.27 ± 0.13

0.72

IGF-I SDS

0.78 ± 0.88

0.62 ± 0.69

0.45 ± 0.83

0.72

IGF-I/IGFBP-3

0.43 ± 0.12

0.41 ± 0.11

0.39 ± 0.09

0.86